Analyzing the evolution and bacterial clearance of Clostridioides difficile infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients hospitalized with microbiologically documented Clostridioides difficile infections or recurrences. It aims to analyze the clinical evolution of the infection and the effectiveness of bacterial clearance methods. The study will involve French-speaking patients over 18 years of age who consent to participate. Data will be collected from patients treated at the Fondation Hôpital Saint-Joseph in Paris.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients over 18 years of age
* Patients hospitalized in a department of GH Paris Saint-Joseph with a microbiologically documented Clostridioides difficile infection or a microbiologically documented Clostridioides difficile recurrence.
* Patient to be treated for Clostridioides difficile infection
* French-speaking patient
* Patients who do not object to their participation in the study

Exclusion Criteria:

* Patients under guardianship or curatorship
* Patient deprived of liberty
* Patient under court protection
* Pregnant or breast-feeding patient

Where it's running

• Fondation Hôpital Saint-Joseph
  Paris, France Recruiting

Study contacts

• Principal investigator: Assaf MIZRAHI, MD — Fondation Hôpital Saint-Joseph
• Study coordinator: Assaf MIZRAHI, MD
• Email: amizrahi@ghpsj.fr
• Phone: 144127030

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for fecal microbiota transplants in Clostridium difficile infections

  This study is creating a national registry to see how well fecal microbiota transplants work for people with Clostridium difficile infections and to gather information about the process and any side effects.

  Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT06311006

• VE303 for preventing recurrent Clostridioides difficile infections

  This study is testing a new treatment called VE303 to see if it can help prevent Clostridioides difficile infections from coming back in people who are at high risk.

  Recruiting at 130 sites Phase 3 Vedanta Biosciences, Inc. · Huntsville, Alabama and 214 other locations · NCT06237452

• How long to take two blood-thinning medicines after leg artery procedures in CLTI

  This study tests whether a shorter course of dual antiplatelet therapy after below-the-knee artery revascularization helps people with chronic limb threatening ischemia.

  Recruiting Phase 3 Fondation Hôpital Saint-Joseph · Paris, Île-de-France Region · NCT07512960

• Hypnosis to improve comfort during transoesophageal echocardiography

  This trial will test whether conversational and brief hypnosis given by the cardiologist can make transoesophageal echocardiography easier and less uncomfortable for adults having the procedure with local anaesthetic.

  Recruiting Fondation Hôpital Saint-Joseph · Paris, Île-de-France Region · NCT07512830

• Digital care-coordination support for family caregivers after an emergency-department discharge

  This pilot tests whether the Monka digital app helps family caregivers of adults discharged from the emergency department reduce caregiver burden and improve post-discharge outcomes.

  Recruiting Fondation Hôpital Saint-Joseph · Paris · NCT07348081

• Music during nursing care to improve comfort after an acute stroke in the neurovascular ICU

  We will see if playing music during nursing care helps adults hospitalized in the neurovascular ICU after an acute stroke feel more comfortable.

  Recruiting Fondation Hôpital Saint-Joseph · Paris · NCT07313163

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.